Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Wilms Tumor × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 36 Triple Negative Breast Neoplasms 16 Carcinoma, Transitional Cell 14 Breast Neoplasms 14 Small Cell Lung Carcinoma 12 Urinary Bladder Neoplasms 11 Melanoma 10 Carcinoma, Hepatocellular 9 Neoplasms 8 Carcinoma, Renal Cell 8 Uterine Cervical Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Lymphoma, Follicular 4 Lymphoma 4 Recurrence 3 Leukemia, Myeloid, Acute 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Kidney Neoplasms 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2

Interventions

X-Rays 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Phantoms, Imaging 5 Vincristine 4 Nuclear Medicine Department, Hospital 4 Doxorubicin 4 Dactinomycin 4 Radiotherapy 3 Biopsy 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 Vemurafenib 2 Radiotherapy, Conformal 2 Radiation 2 LY3023414 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 thymoglobulin 1 sargramostim 1 pembrolizumab 1 lorvotuzumab mertansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡